Nussenzweig V - Search Results

1

Antisporozoite vaccine for malaria: experimental basis and current status.

Nussenzweig RS, Nussenzweig V. Nussenzweig RS, et al. Among authors: nussenzweig v. Rev Infect Dis. 1989 May-Jun;11 Suppl 3:S579-85. doi: 10.1093/clinids/11.supplement_3.s579. Rev Infect Dis. 1989. PMID: 2669101 Review.

2

Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model.

Tao D, Barba-Spaeth G, Rai U, Nussenzweig V, Rice CM, Nussenzweig RS. Tao D, et al. Among authors: nussenzweig rs, nussenzweig v. J Exp Med. 2005 Jan 17;201(2):201-9. doi: 10.1084/jem.20041526. J Exp Med. 2005. PMID: 15657290 Free PMC article.

3

Human CD8+ T cells mediate protective immunity induced by a human malaria vaccine in human immune system mice.

Li X, Huang J, Zhang M, Funakoshi R, Sheetij D, Spaccapelo R, Crisanti A, Nussenzweig V, Nussenzweig RS, Tsuji M. Li X, et al. Among authors: nussenzweig v. Vaccine. 2016 Aug 31;34(38):4501-4506. doi: 10.1016/j.vaccine.2016.08.006. Epub 2016 Aug 5. Vaccine. 2016. PMID: 27502569 Free PMC article.

4

Rationale for the development of an engineered sporozoite malaria vaccine.

Nussenzweig V, Nussenzweig RS. Nussenzweig V, et al. Among authors: nussenzweig rs. Adv Immunol. 1989;45:283-334. doi: 10.1016/s0065-2776(08)60695-1. Adv Immunol. 1989. PMID: 2665440 Review. No abstract available.

5

Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites.

Schofield L, Villaquiran J, Ferreira A, Schellekens H, Nussenzweig R, Nussenzweig V. Schofield L, et al. Among authors: nussenzweig r, nussenzweig v. Nature. 1987 Dec 17-23;330(6149):664-6. doi: 10.1038/330664a0. Nature. 1987. PMID: 3120015

6

Synthetic peptide vaccine confers protection against murine malaria.

Zavala F, Tam JP, Barr PJ, Romero PJ, Ley V, Nussenzweig RS, Nussenzweig V. Zavala F, et al. Among authors: nussenzweig rs, nussenzweig v. J Exp Med. 1987 Nov 1;166(5):1591-6. doi: 10.1084/jem.166.5.1591. J Exp Med. 1987. PMID: 3316473 Free PMC article.

7

Induction of sporozoite-specific memory cells in mice immunized with a recombinant Plasmodium vivax circumsporozoite protein.

Nardin EH, Barr PJ, Gibson HL, Collins WE, Nussenzweig RS, Nussenzweig V. Nardin EH, et al. Among authors: nussenzweig rs, nussenzweig v. Eur J Immunol. 1987 Dec;17(12):1763-7. doi: 10.1002/eji.1830171213. Eur J Immunol. 1987. PMID: 3319650

8

Pre-erythrocytic malaria vaccine: mechanisms of protective immunity and human vaccine trials.

Nardin E, Zavala F, Nussenzweig V, Nussenzweig RS. Nardin E, et al. Among authors: nussenzweig rs, nussenzweig v. Parassitologia. 1999 Sep;41(1-3):397-402. Parassitologia. 1999. PMID: 10697892 Review.

9

Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria.

Tam JP, Clavijo P, Lu YA, Nussenzweig V, Nussenzweig R, Zavala F. Tam JP, et al. Among authors: nussenzweig r, nussenzweig v. J Exp Med. 1990 Jan 1;171(1):299-306. doi: 10.1084/jem.171.1.299. J Exp Med. 1990. PMID: 1688609 Free PMC article.

10

Progress toward a malaria vaccine.

Nussenzweig V, Nussenzweig RS. Nussenzweig V, et al. Among authors: nussenzweig rs. Hosp Pract (Off Ed). 1990 Sep 15;25(9):45-52, 55-7. doi: 10.1080/21548331.1990.11703995. Hosp Pract (Off Ed). 1990. PMID: 2118918

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

295 results

Search Page

Filters